Skip to content
DataLookout
Menu

NCT07613281

Serene Sleep Palatal Implant System Clinical Confirmatory Trial in Participants Who Snore or Are Diagnosed With Mild-to-moderate Obstructive Sleep Apnea (OSA).

StatusEnrolling by Invitation
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved at least 32 days later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Enrolling by invitation only Show 6 more changesShow less
    • Eligibility criteria expanded, about 41 words
    • Primary completion pushed from Sep 2026 to Nov 2026
    • Study completion date: Oct 2026 to Nov 2026
    • Start date changed from estimate of Jun 2026 to Jun 17, 2026
    • Secondary endpoints: details revised at 1 of 2 entries
    • Site contacts updated at 2 of 2 sites
  2. Notable Phase changed: Not specified → Not applicablev2 Show 9 more changesShow less
    • Primary endpoint(s) modified
    • Sponsor changed: [Redacted] to Serene Sleep, Inc.
    • Trial status changed: Withheld → Not Yet Recruiting
    • Enrollment changed: None → 26
    • Trial arms changed: 0 → 2
    • Primary completion date: Sep 2026
    • Study completion date: Oct 2026
    • Start date: Jun 2026
    • Study title expanded, about 8 words
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Proportion of Participants with Implant Extrusion at 30 Days and Absence of Serious Adverse Device Effects (SADEs) [Hybrid Composite Safety Endpoint]
Timeframe: From baseline to 30 days post-procedure

Secondary (2)

Change is Visual Analogue Scale (VAS) Score
Change in Snoring Outcomes Survey (SOS)

Arms and interventions

Snoring GroupExperimental

Implant with the Serene Sleep Palatal Implant System

Mild to Moderate OSA GroupExperimental

Implant with the Serene Sleep Palatal Implant System

Devices: Palatal Implant System

Sites

2 sites in 1 country